Literature DB >> 24296612

More than a billion people taking statins?: Potential implications of the new cardiovascular guidelines.

John P A Ioannidis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24296612     DOI： 10.1001/jama.2013.284657

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  67 in total

1.  Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Joseph Yeboah; Stefan Sillau; Joseph C Delaney; Michael J Blaha; Erin D Michos; Rebekah Young; Waqas T Qureshi; Robyn McClelland; Gregory L Burke; Bruce M Psaty; David M Herrington
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

2.  Statin-induced calcific Achilles tendinopathy in rats: comparison of biomechanical and histopathological effects of simvastatin, atorvastatin and rosuvastatin.

Authors:  Ferda Kaleağasıoğlu; Ercan Olcay; Vakur Olgaç
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-15       Impact factor: 4.342

3.  The new lipid guidelines: what do primary care clinicians think?

Authors:  Sina Jamé; Eve Wittenberg; Michael B Potter; Kirsten E Fleischmann
Journal:  Am J Med       Date:  2015-03-30       Impact factor: 4.965

4.  Effects of SLCO1B1 and GATM gene variants on rosuvastatin-induced myopathy are unrelated to high plasma exposure of rosuvastatin and its metabolites.

Authors:  Xue Bai; Bin Zhang; Ping Wang; Guan-Lei Wang; Jia-Li Li; Ding-Sheng Wen; Xing-Zhen Long; Hong-Shuo Sun; Yi-Bin Liu; Min Huang; Shi-Long Zhong
Journal:  Acta Pharmacol Sin       Date:  2018-06-27       Impact factor: 6.150

5.  An image-based small-molecule screen identifies vimentin as a pharmacologically relevant target of simvastatin in cancer cells.

Authors:  Kathryn P Trogden; Rachel A Battaglia; Parijat Kabiraj; Victoria J Madden; Harald Herrmann; Natasha T Snider
Journal:  FASEB J       Date:  2018-01-18       Impact factor: 5.191

6.  Statin treatment for older adults: the impact of the 2013 ACC/AHA cholesterol guidelines.

Authors:  Yitzchak Weinberger; Benjamin H Han
Journal:  Drugs Aging       Date:  2015-02       Impact factor: 3.923

7.  Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study.

Authors:  Xuemei Huang; Alvaro Alonso; Xuguang Guo; David M Umbach; Maya L Lichtenstein; Christie M Ballantyne; Richard B Mailman; Thomas H Mosley; Honglei Chen
Journal:  Mov Disord       Date:  2015-01-14       Impact factor: 10.338

Review 8.  Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?

Authors:  Ian M Graham; Alberico L Catapano
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

Review 9.  Statins and Cataracts--a visual insight.

Authors:  Jeanne M Dobrzynski; John B Kostis
Journal:  Curr Atheroscler Rep       Date:  2015       Impact factor: 5.113

10.  Trends in statin therapy initiation during the period 2000-2010 in Israel.

Authors:  Varda Shalev; Clara Weil; Raanan Raz; Inbal Goldshtein; Dahlia Weitzman; Gabriel Chodick
Journal:  Eur J Clin Pharmacol       Date:  2014-01-25       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.